Figure 3 . Percentage of plasmatic inhibition of DβH activity at pre-dose (trough) following administration of zamicastat 400 mg (once daily) and placebo (PP-PD population, n = 21).
(DβH: dopamine-β-hydroxylase; PP-PD: per-protocol pharmacodynamics).